Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 15

    1.

    SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.

    Liu KS, Liu H, Qi JH, Liu QY, Liu Z, Xia M, Xing GW, Wang SX, Wang YF.

    Cancer Lett. 2012 May 28;318(2):180-8. doi: 10.1016/j.canlet.2011.12.015. Epub 2011 Dec 17.

    PMID:
    22182451
    [PubMed - indexed for MEDLINE]
    2.

    Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma.

    Dunn JH, Ellis LZ, Fujita M.

    Cancer Lett. 2012 Jan 1;314(1):24-33. Epub 2011 Oct 12. Review.

    PMID:
    22050907
    [PubMed - indexed for MEDLINE]
    3.

    Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism.

    Sánchez-Hernández I, Baquero P, Calleros L, Chiloeches A.

    Cancer Lett. 2012 Jan 28;314(2):244-55. Epub 2011 Oct 8.

    PMID:
    22056813
    [PubMed - indexed for MEDLINE]
    4.

    Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction.

    Hiwatashi K, Tamiya T, Hasegawa E, Fukaya T, Hashimoto M, Kakoi K, Kashiwagi I, Kimura A, Inoue N, Morita R, Yasukawa H, Yoshimura A.

    Cancer Lett. 2011 Sep 28;308(2):172-80. Epub 2011 May 31.

    PMID:
    21624767
    [PubMed - indexed for MEDLINE]
    5.

    Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes.

    Chalkiadaki G, Nikitovic D, Katonis P, Berdiaki A, Tsatsakis A, Kotsikogianni I, Karamanos NK, Tzanakakis GN.

    Cancer Lett. 2011 Dec 22;312(2):235-44. doi: 10.1016/j.canlet.2011.08.016. Epub 2011 Aug 22.

    PMID:
    21906873
    [PubMed - indexed for MEDLINE]
    6.

    A novel C-terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells.

    Samadi AK, Zhang X, Mukerji R, Donnelly AC, Blagg BS, Cohen MS.

    Cancer Lett. 2011 Dec 22;312(2):158-67. doi: 10.1016/j.canlet.2011.07.031. Epub 2011 Aug 22.

    PMID:
    21924824
    [PubMed - indexed for MEDLINE]
    7.

    The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.

    Scuderi MR, Cantarella G, Scollo M, Lempereur L, Palumbo M, Saccani-Jotti G, Bernardini R.

    Cancer Lett. 2011 Nov 28;310(2):240-9. Epub 2011 Jul 19.

    PMID:
    21807457
    [PubMed - indexed for MEDLINE]
    8.

    Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.

    van Sluis GL, Brüggemann LW, Esmon CT, Kamphuisen PW, Richel DJ, Büller HR, van Noorden CJ, Spek CA.

    Cancer Lett. 2011 Jul 1;306(1):106-10. Epub 2011 Mar 21.

    PMID:
    21420234
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization.

    Zhang JP, Qin HY, Wang L, Liang L, Zhao XC, Cai WX, Wei YN, Wang CM, Han H.

    Cancer Lett. 2011 Oct 28;309(2):220-7. Epub 2011 Jun 24.

    PMID:
    21752535
    [PubMed - indexed for MEDLINE]
    10.

    Mutual enhancement between heparanase and vascular endothelial growth factor: a novel mechanism for melanoma progression.

    Luan Q, Sun J, Li C, Zhang G, Lv Y, Wang G, Li C, Ma C, Gao T.

    Cancer Lett. 2011 Sep 1;308(1):100-11. Epub 2011 May 31.

    PMID:
    21624769
    [PubMed - indexed for MEDLINE]
    11.

    Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.

    Verbeke H, Struyf S, Berghmans N, Van Coillie E, Opdenakker G, Uyttenhove C, Van Snick J, Van Damme J.

    Cancer Lett. 2011 Mar 1;302(1):54-62. Epub 2011 Jan 13.

    PMID:
    21236563
    [PubMed - indexed for MEDLINE]
    12.

    Melanoma-associated antigen genes - an update.

    Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L, Lian Y, Shan B.

    Cancer Lett. 2011 Mar 28;302(2):85-90. Epub 2010 Nov 19. Review.

    PMID:
    21093980
    [PubMed - indexed for MEDLINE]
    13.

    A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells.

    Mehta PP, Kung PP, Yamazaki S, Walls M, Shen A, Nguyen L, Gehring MR, Los G, Smeal T, Yin MJ.

    Cancer Lett. 2011 Jan 1;300(1):30-9.

    PMID:
    20926183
    [PubMed - indexed for MEDLINE]
    14.

    Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.

    Cao Q, Jin Y, Jin M, He S, Gu Q, He S, Qiu Y, Ge H, Yoneyama H, Zhang Y.

    Cancer Lett. 2010 Sep 1;295(1):17-26. Epub 2010 Mar 3.

    PMID:
    20202744
    [PubMed - indexed for MEDLINE]
    15.

    Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.

    Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ, Zheng JN.

    Cancer Lett. 2010 Aug 28;294(2):220-8. Epub 2010 Feb 26.

    PMID:
    20189296
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk